MAML1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.706580E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.398800E-01
Normal-vs-Stage2
1.827160E-01
Normal-vs-Stage3
1.319710E-02
Normal-vs-Stage4
9.943000E-01
Stage1-vs-Stage2
4.770400E-01
Stage1-vs-Stage3
2.849600E-02
Stage1-vs-Stage4
5.168600E-01
Stage2-vs-Stage3
3.958400E-02
Stage2-vs-Stage4
1.274430E-01
Stage3-vs-Stage4
5.551600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.648350E-01
Normal-vs-AfricanAmerican
2.777800E-01
Normal-vs-Asian
2.970800E-01
Caucasian-vs-AfricanAmerican
8.403200E-01
Caucasian-vs-Asian
7.120000E-01
AfricanAmerican-vs-Asian
7.563600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.046800E-01
Normal-vs-Female
1.434800E-01
Male-vs-Female
9.892200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.843200E-01
Normal-vs-Age(41-60Yrs)
4.636600E-01
Normal-vs-Age(61-80Yrs)
1.053830E-01
Normal-vs-Age(81-100Yrs)
2.958000E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.147800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.887600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.396640E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.648700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.663000E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.891800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.547020E-01
Normal-vs-Daily Drinker
1.754580E-01
Normal-vs-Weekly Drinker
1.646020E-01
Normal-vs-Occasional Drinker
1.684210E-01
Normal-vs-Social Drinker
2.296800E-01
Non Drinker-vs-Daily Drinker
9.789600E-01
Non Drinker-vs-Weekly Drinker
9.160800E-01
Non Drinker-vs-Occasional Drinker
6.313400E-01
Non Drinker-vs-Social Drinker
2.417000E-01
Daily Drinker-vs-Weekly Drinker
9.389000E-01
Daily Drinker-vs-Occasional Drinker
6.707800E-01
Daily Drinker-vs-Social Drinker
2.767200E-01
Weekly Drinker-vs-Occasional Drinker
7.451400E-01
Weekly Drinker-vs-Social Drinker
3.139800E-01
Occasional Drinker-vs-Social Drinker
4.508400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.700640E-01
Normal-vs-Grade 2
1.177940E-02
Normal-vs-Grade 3
1.273960E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.798500E-02
Grade 1-vs-Grade 3
3.513700E-02
Grade 1-vs-Grade 4
1.700640E-01
Grade 2-vs-Grade 3
4.622000E-01
Grade 2-vs-Grade 4
1.177940E-02
Grade 3-vs-Grade 4
1.273960E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.093440E-01
Normal-vs-NonDiabetic
1.502830E-01
Diabetic-vs-NonDiabetic
3.998000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.162200E-01
Normal-vs-NoPancreatitis
1.440830E-01
Pancreatitis-vs-NoPancreatitis
3.987800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.530640E-01
Normal-vs-N1
1.872840E-01
N0-vs-N1
5.184400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.117800E-01
Normal-vs-TP53-NonMutant
3.607600E-01
TP53-Mutant-vs-TP53-NonMutant
9.881200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
